The effect of sesamol on systemic oxidative stress and hepatic dysfunction in acutely iron-intoxicated mice

Shock

Volumn 28, Issue 5, 2007, Pages 596-601

  Hsu, Dur Zong ^a   Chien, Se Ping ^b   Chen, Ke Ting ^a   Liu, Ming Yie ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

Fenton reaction; Haber Weiss reaction; Iron intoxication; Lipid peroxidation; Xanthine oxidase

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; HYDROXYL RADICAL; IRON; SESAMOL; SUPEROXIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; IRON OVERLOAD; LIPID PEROXIDATION; LIVER DYSFUNCTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS;

ACUTE DISEASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; BENZODIOXOLES; HYDROXYL RADICAL; IRON; LIPID PEROXIDATION; LIVER; MALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; PHENOLS; SUPEROXIDES; XANTHINE OXIDASE;

EID: 37349079471     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31804d4474     Document Type: Article

References (43)

1. Engle JP, Polin KS, Stile IL: Acute iron intoxication: treatment controversies. Drug Intell Clin Pharm 21:153-159, 1987.
2. Anderson A: Iron poisoning in children. Curr Opin Pediatr 6:289-294, 1994.
3. Fine JS: Iron poisoning. Curr Probl Pediatr 30:71-90, 2000.
4. Yang Q, McDonnel SM, Khoury MJ, Cono J, Parrish RG: Hemochromatosis- associated mortality in the United States from 1979 to 1992: an analysis of multiple cause mortality data. Ann Intern Med 129:946-953, 1998.
5. Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K: Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80:737-744, 2001.
6. Rasmussen M, Folsom AR, Catellier DJ, Tsai MY, Garg U, Eckfeldt JH: A prospective study of coronary heart disease and the hemochromatosis gene (HEF) C282Y mutation: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 154:739-746, 2001.
7. Backman LE, Van Landeghem GF, Sikstrom C, Wahlin A, Markevarn B, Hallmans G, Lenner P, Athlin L, Stenling R, Backman L: Interaction between haemochromatosis and transferring receptor genes in different neoplastic disorders. Carcinogenesis 20:1231-1233, 1999.
8. Parkkila S, Niemela O, Savolainen ER, Koistinen P: HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia. Transfusion 41:828-831, 2001.
9. Sayre LM, Perry G, Atwood CS, Smith MA: The role of metals in neurodegenerative diseases. Cell Mol Biol 46:731-741, 2000.
10. Berg D, Gerlach M, Youdim MB, Double KL, Zecca L, Riederer P, Becker G: Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 79:225-236, 2001.
11. Perez de Nanclares G, Gastano L, Gaztambide S, Bilbao JR, Pi J, Gonzalez ML, Vazquez JA: Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis. N Engl J Med 343:890-891, 2000.
12. Wilkinson H: Haemochromatosis associated with arthritis and hypopituitarism. Ann Clin Biochem 333:171-173, 1996. Erratum in: Ann Clin Biochem 33:366, 1996.
13. Walker EM Jr, Walker SM: Effects of iron overload on the immune system. Ann Clin Lab Sci 30:354-365, 2000.
14. Matsuura R: Uptake of iron and nitrilotriacetate (NTA) in rat liver and the toxic effect of Fe-NTA. Acta Med Okayama 37:393-400, 1983.
15. Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O: Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 76:107-113, 1986.
16. Suntres ZE, Shek PN: Treatment of LPS-induced tissue injury: role of liposomal antioxidants. Shock 6:S57-S64, 1996.
17. Vega VL, Maldonado M, Mardones L, Manriquez V, Vivaldi E, Roa J, Ward PH: Inhibition of nitric oxide synthesis aggravates hepatic oxidative stress and enhances superoxide dismutase inactivation in rats subjected to tourniquet shock. Shock 9:320-328, 1998.
18. Kawabata T, Awai M, Kohno M: Generation of active oxygen species by iron nitrilotriacetate (Fe-NTA). Acta Medica Okayama 40:163-173, 1986.
19. 2)-induced peroxidation of microsomal membrane lipids and DNA damage. Teratog Carcinog Mutagen suppl 1:151-160, 2003.
20. Gutteridge JM: Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201:291-295, 1986.
21. Freeman B, Crapo JD: Biology of disease: free radicals and tissue injury. Lab Invest 47:412-426, 1982.
22. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H: Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31:1048-1052, 2003.
23. Lovat R, Preiser JC: Antioxidant therapy in intensive care. Crit Care Med 9:266-270, 2003.
24. Bela P, Bahl R, Sane AS, Sawant PH, Shah VR, Mishra VV, Trivedi HL: Oxidative stress status: possible guideline for clinical management of critically ill patients. Panminerva Med 43:27-31, 2001.
25. Agarwal R, Vasavada N, Sachs NG, Chase S: Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int 65:2279-2289, 2004.
26. Umemura T, Hasegawa R, Sai-Kato K, Nishikawa A, Furukawa F, Toyokuni S, Uchida K, Inoue T, Kurokawa Y: Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate. Jpn J Cancer Res 87:882-886, 1996.
27. Emerit J, Beaumont C, Trivin F: Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother 55:333-339, 2001.
28. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624, 1990.
29. Pacher P, Nivorozhkin A, Szabo C: Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58:87-114, 2006.
30. Hsu DZ, Liu MY: Effects of sesame oil on oxidative stress after the onset of sepsis in rats. Shock 22:582-585, 2004.
31. Hsu DZ, Li YH, Chien SP, Liu MY: Effects of sesame oil on oxidative stress and hepatic injury after cecal ligation and puncture in rats. Shock 21:466-469, 2004.
32. Fukuda Y: Food chemical studies on the antioxidants in sesame seed. Nippon Shokuhin Kogyo Gakkaishi 37:484-492, 1990.
33. Hsu DZ, Chen KT, Chien SP, Li YH, Huang BM, Chuang YC, Liu MY: Sesame oil attenuates acute iron-induced lipid-peroxidation-associated hepatic damage in mice. Shock 26:625-630, 2006.
34. Hsu DZ, Li YH, Chu PY, Chien SP, Chuang YC, Liu MY: Attenuation of endotoxin-induced oxidative stress and multiple organ injury by 3,4-methylenedioxyphenol in rats. Shock 25:300-305, 2006.
35. Hsu DZ, Chen KT, Li YH, Chuang YC, Liu MY: Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress. Shock 25:528-532, 2006.
36. Uchida M, Nakajin S, Toyoshima S, Shinoda M: Antioxidative effect of sesamol and related compounds on lipid peroxidation. Biol Pharm Bull 19:623-626, 1996.
37. Zhang D, Yasuda T, Yu Y, Zheng P, Kawabata T, Ma Y, Okada S: Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation. Free Radic Biol Med 20:145-150, 1996.
38. Carter P: Spectrophotometric determination of serum iron at the submicrogram level with a new reagent (ferrozine). Anal Biochem 40:450-458, 1971.
39. Liu M, Okada S, Kawabata T: Radical promoting free iron level in the serum of rats treated with ferric nitrilotriacetate; comparison with other iron chelate complexes. Acta Med Okayama 45:401-408, 1991.
40. Fang YZ, Yang S, Wu G: Free radicals, antioxidants, and nutrition. Nutrition 18:872-879, 2002.
41. Howsawkeng J, Watts RJ, Washington DL, Teel AL, Hess TF, Crawford RL: Evidence for simultaneous abiotic-biotic oxidations in a microbial-Fenton's system. Environ Sci Technol 35:2961-2966, 2001.
42. Hsu DZ, Liu MY: Sesame oil attenuates multiple organ failure and increases survival rate during endotoxemia in rats. Crit Care Med 30:1859-1862, 2002.
43. Koren G, Bentur Y, Strong D, Harvey E, Klein J, Baumal R, Spielberg SP, Freedman MH: Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child 143:1077-1080, 1989.